U
Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
D
Sell
5/20/2020Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D from D- on 5/20/2020 due to a substantial increase in the growth index. Operating cash flow increased 85.78% from -$366.5 to -$52.1.
Applied Biosciences Corp. (APPB) was upgraded to D from D- on 5/20/2020 due to a substantial increase in the growth index. Operating cash flow increased 85.78% from -$366.5 to -$52.1.
D
Sell
7/16/2019Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 7/16/2019 due to a significant increase in the solvency index, growth index and valuation index.
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 7/16/2019 due to a significant increase in the solvency index, growth index and valuation index.
E
Sell
7/1/2019Downgrade
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 7/1/2019 due to a significant decline in the solvency index, growth index and total return index.
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 7/1/2019 due to a significant decline in the solvency index, growth index and total return index.
D
Sell
5/28/2019Downgrade
Applied Biosciences Corp. (APPB) was downgraded to D- from D on 5/28/2019 due to a decline in the volatility index, total return index and valuation index.
Applied Biosciences Corp. (APPB) was downgraded to D- from D on 5/28/2019 due to a decline in the volatility index, total return index and valuation index.
D
Sell
5/2/2019Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D from D- on 5/2/2019 due to an increase in the total return index, volatility index and valuation index.
Applied Biosciences Corp. (APPB) was upgraded to D from D- on 5/2/2019 due to an increase in the total return index, volatility index and valuation index.
D
Sell
4/15/2019Downgrade
Applied Biosciences Corp. (APPB) was downgraded to D- from D on 4/15/2019 due to a decline in the volatility index.
Applied Biosciences Corp. (APPB) was downgraded to D- from D on 4/15/2019 due to a decline in the volatility index.
D
Sell
3/29/2019Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D from D- on 3/29/2019 due to an increase in the volatility index, total return index and valuation index.
Applied Biosciences Corp. (APPB) was upgraded to D from D- on 3/29/2019 due to an increase in the volatility index, total return index and valuation index.
D
Sell
2/15/2019Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 2/15/2019 due to an increase in the efficiency index and valuation index. Total capital increased 122.94% from $729 to $1.63M.
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 2/15/2019 due to an increase in the efficiency index and valuation index. Total capital increased 122.94% from $729 to $1.63M.
E
Sell
9/10/2018Downgrade
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 9/10/2018 due to a decline in the valuation index, volatility index and total return index.
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 9/10/2018 due to a decline in the valuation index, volatility index and total return index.
D
Sell
8/17/2018Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 8/17/2018 due to a major increase in the growth index, solvency index and efficiency index. Net income increased 76.24% from -$1.66M to -$395.5, earnings per share increased from -$0.1197 to -$0.0377, and operating cash flow increased 35.92% from -$252.8 to -$162.
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 8/17/2018 due to a major increase in the growth index, solvency index and efficiency index. Net income increased 76.24% from -$1.66M to -$395.5, earnings per share increased from -$0.1197 to -$0.0377, and operating cash flow increased 35.92% from -$252.8 to -$162.
E
Sell
8/9/2018Downgrade
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 8/9/2018 due to a decline in the total return index and volatility index.
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 8/9/2018 due to a decline in the total return index and volatility index.
D
Sell
7/20/2018Upgraded
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 7/20/2018 due to an increase in the volatility index and valuation index.
Applied Biosciences Corp. (APPB) was upgraded to D- from E+ on 7/20/2018 due to an increase in the volatility index and valuation index.
E
Sell
7/5/2018Downgrade
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 7/5/2018 due to a noticeable decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.0215 to -$0.1197, EBIT declined 126.22% from -$342.9 to -$775.7, and total revenue declined 71.43% from $63 to $18.
Applied Biosciences Corp. (APPB) was downgraded to E+ from D- on 7/5/2018 due to a noticeable decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.0215 to -$0.1197, EBIT declined 126.22% from -$342.9 to -$775.7, and total revenue declined 71.43% from $63 to $18.
D
Sell
2/16/2018Downgrade
Stony Hill Corp. (STNY) was downgraded to D- from D on 2/16/2018 due to a decline in the efficiency index, total return index and growth index. EBIT declined 93.29% from -$177.4 to -$342.9, net income declined 89.23% from -$177.4 to -$335.7, and earnings per share declined from -$0.0116 to -$0.0215.
Stony Hill Corp. (STNY) was downgraded to D- from D on 2/16/2018 due to a decline in the efficiency index, total return index and growth index. EBIT declined 93.29% from -$177.4 to -$342.9, net income declined 89.23% from -$177.4 to -$335.7, and earnings per share declined from -$0.0116 to -$0.0215.
D
Sell
2/1/2018Upgraded
Stony Hill Corp. (STNY) was upgraded to D from D- on 2/1/2018 due to an increase in the total return index, volatility index and efficiency index. Total capital increased 33.81% from $1.51M to $2.01M, and net income increased 10.58% from -$198.4 to -$177.4.
Stony Hill Corp. (STNY) was upgraded to D from D- on 2/1/2018 due to an increase in the total return index, volatility index and efficiency index. Total capital increased 33.81% from $1.51M to $2.01M, and net income increased 10.58% from -$198.4 to -$177.4.
D
Sell
10/2/2017Upgraded
Stony Hill Corp. (STNY) was upgraded to D- from E on 10/2/2017 due to an increase in the volatility index.
Stony Hill Corp. (STNY) was upgraded to D- from E on 10/2/2017 due to an increase in the volatility index.
E
Sell
7/5/2017Upgraded
Stony Hill Corp. (STNY) was upgraded to E from E- on 7/5/2017 due to a major increase in the solvency index, growth index and efficiency index. Total capital increased 473% from $287 to $1.64M, earnings per share increased from -$0.0311 to -$0.005, and net income increased 82.43% from -$413.7 to -$72.7.
Stony Hill Corp. (STNY) was upgraded to E from E- on 7/5/2017 due to a major increase in the solvency index, growth index and efficiency index. Total capital increased 473% from $287 to $1.64M, earnings per share increased from -$0.0311 to -$0.005, and net income increased 82.43% from -$413.7 to -$72.7.
E
Sell
6/15/2017Downgrade
Stony Hill Corp. (STNY) was downgraded to E- from E on 6/15/2017 due to a decline in the volatility index.
Stony Hill Corp. (STNY) was downgraded to E- from E on 6/15/2017 due to a decline in the volatility index.
E
Sell
4/25/2017None
Applied Biosciences Corp. (APPB) was downgraded to E from U on 04/25/2017.
Applied Biosciences Corp. (APPB) was downgraded to E from U on 04/25/2017.
OTC PK
10/01/2024 3:21PM Eastern
Quotes delayed
